BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24905374)

  • 1. Emerging drugs of abuse: clinical and legal considerations.
    Aoun EG; Christopher PP; Ingraham JW
    R I Med J (2013); 2014 Jun; 97(6):41-5. PubMed ID: 24905374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bath salts and other emerging toxins.
    Thornton MD; Baum CR
    Pediatr Emerg Care; 2014 Jan; 30(1):47-52; quiz 53-5. PubMed ID: 24378862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicology and management of novel psychoactive drugs.
    Kersten BP; McLaughlin ME
    J Pharm Pract; 2015 Feb; 28(1):50-65. PubMed ID: 25261428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Changing Drug Culture: Emerging Drugs of Abuse and Legal Highs.
    Albertson TE; Chenoweth JA; Colby DK; Sutter ME
    FP Essent; 2016 Feb; 441():18-24. PubMed ID: 26881769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food".
    Coppola M; Mondola R
    Toxicol Lett; 2012 Jun; 211(2):144-9. PubMed ID: 22459606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging drugs of abuse.
    Nelson ME; Bryant SM; Aks SE
    Emerg Med Clin North Am; 2014 Feb; 32(1):1-28. PubMed ID: 24275167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New drugs of abuse.
    Rech MA; Donahey E; Cappiello Dziedzic JM; Oh L; Greenhalgh E
    Pharmacotherapy; 2015 Feb; 35(2):189-97. PubMed ID: 25471045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Synthetic drugs: the new low-cost landscape of drugs].
    Karila L; Petit A; Cottencin O; Coscas S; Reynaud M
    Rev Prat; 2012 May; 62(5):664-6. PubMed ID: 22730798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Not for human consumption": a review of emerging designer drugs.
    Musselman ME; Hampton JP
    Pharmacotherapy; 2014 Jul; 34(7):745-57. PubMed ID: 24710806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Here today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines.
    Rosenbaum CD; Carreiro SP; Babu KM
    J Med Toxicol; 2012 Mar; 8(1):15-32. PubMed ID: 22271566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute kidney injury associated with smoking synthetic cannabinoid.
    Buser GL; Gerona RR; Horowitz BZ; Vian KP; Troxell ML; Hendrickson RG; Houghton DC; Rozansky D; Su SW; Leman RF
    Clin Toxicol (Phila); 2014 Aug; 52(7):664-73. PubMed ID: 25089722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence and properties of spice and bath salts: a medicinal chemistry perspective.
    Lewin AH; Seltzman HH; Carroll FI; Mascarella SW; Reddy PA
    Life Sci; 2014 Feb; 97(1):9-19. PubMed ID: 24113072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical toxicology of emerging drugs of abuse--an update.
    Meyer MR; Peters FT
    Ther Drug Monit; 2012 Dec; 34(6):615-21. PubMed ID: 23131695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States.
    Spiller HA; Ryan ML; Weston RG; Jansen J
    Clin Toxicol (Phila); 2011 Jul; 49(6):499-505. PubMed ID: 21824061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spice drugs as a new trend: mode of action, identification and legislation.
    Vardakou I; Pistos C; Spiliopoulou Ch
    Toxicol Lett; 2010 Sep; 197(3):157-62. PubMed ID: 20566335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Khat and synthetic cathinones: a review.
    Valente MJ; Guedes de Pinho P; de Lourdes Bastos M; Carvalho F; Carvalho M
    Arch Toxicol; 2014 Jan; 88(1):15-45. PubMed ID: 24317389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baths salts, spice, and related designer drugs: the science behind the headlines.
    Baumann MH; Solis E; Watterson LR; Marusich JA; Fantegrossi WE; Wiley JL
    J Neurosci; 2014 Nov; 34(46):15150-8. PubMed ID: 25392483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designer drugs. Patients may be using synthetic cannabinoids more than you think.
    Lisi DM
    JEMS; 2014 Sep; 39(9):56-9. PubMed ID: 25322519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Drugs of Abuse.
    Wang GS; Hoyte C
    Pediatr Rev; 2019 Feb; 40(2):71-78. PubMed ID: 30709973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Legal Highs"--An Emerging Epidemic of Novel Psychoactive Substances.
    Zawilska JB
    Int Rev Neurobiol; 2015; 120():273-300. PubMed ID: 26070762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.